ArticleAmerican journal of preventive cardiology2026

Real-world treatment adherence and persistence among patients initiating inclisiran or PCSK9 mAbs.

Robert S Rosenson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.